A detailed history of Ellerson Group Inc /Adv transactions in Amgen Inc stock. As of the latest transaction made, Ellerson Group Inc /Adv holds 11,245 shares of AMGN stock, worth $3.55 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
11,245
Previous 11,275 0.27%
Holding current value
$3.55 Million
Previous $3.25 Billion 1.55%
% of portfolio
2.44%
Previous 2.82%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $8,066 - $9,736
-30 Reduced 0.27%
11,245 $3.2 Billion
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $20,456 - $23,076
80 Added 0.71%
11,275 $3.25 Billion
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $190,225 - $236,170
870 Added 8.43%
11,195 $3.01 Billion
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $177,470 - $216,307
-786 Reduced 7.07%
10,325 $2.5 Billion
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $2.54 Million - $3.23 Million
11,111 New
11,111 $2.92 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ellerson Group Inc /Adv Portfolio

Follow Ellerson Group Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellerson Group Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Ellerson Group Inc /Adv with notifications on news.